Pine River Capital Management’s Emergent Biosolutions EBS Stock Holding History

Pine River Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-284,180	Closed	-$9.33M	–	206
2016 Q4	$9.33M	Hold	284,180	–	–	0.34%	55
2016 Q3	$8.96M	Buy	284,180 +13,190	+5%	+$383K	0.15%	80
2016 Q2	$7.62K	Hold	270,990	–	–	﹤0.01%	125
2016 Q1	$9.85M	Sell	270,990 -104,710	-28%	-$3.7M	0.14%	113
2015 Q4	$15M	Sell	375,700 -31,700	-8%	-$1.11M	0.2%	100
2015 Q3	$11.6M	Hold	407,400	–	–	0.15%	141
2015 Q2	$13.4M	Hold	407,400	–	–	0.15%	136
2015 Q1	$11.7M	Hold	407,400	–	–	0.14%	126
2014 Q4	$11.1M	Hold	407,400	–	–	0.14%	113
2014 Q3	$8.68M	Buy	407,400 +110,200	+37%	+$2.52M	0.1%	185
2014 Q2	$6.67M	Buy	297,200 +81,100	+38%	+$1.89M	0.1%	175
2014 Q1	$5.46M	Buy	+216,100	New	+$5.46M	0.08%	259

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pine River Capital Management's EBS Position: Q1 2017 in Review

Pine River Capital Management sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 284,180 shares — an estimated $9.33M sold.

Pine River Capital Management first reported a position in EBS in Q1 2014 and held it in 12 quarters. The position peaked at $15M in Q4 2015. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

Pine River Capital Management reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
Pine River Capital Management sold 284,180 Emergent Biosolutions shares in Q1 2017, an estimated $9.33M.
Pine River Capital Management first reported a position in Emergent Biosolutions in Q1 2014 and held it in 12 quarters.
Pine River Capital Management's Emergent Biosolutions position peaked at $15M in Q4 2015.
176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Pine River Capital Management's 13F filing for Q1 2017, filed 15 May 2017.